These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 22298893

  • 1. Impact of genomics on personalized cancer medicine.
    Arteaga CL, Baselga J.
    Clin Cancer Res; 2012 Feb 01; 18(3):612-8. PubMed ID: 22298893
    [Abstract] [Full Text] [Related]

  • 2. Personalized medicine: the medicine of tomorrow. Foreword.
    Tremblay-Servier M.
    Metabolism; 2013 Jan 01; 62 Suppl 1():S1. PubMed ID: 23018144
    [No Abstract] [Full Text] [Related]

  • 3. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR, Johnson BE, Sledge GW.
    Clin Cancer Res; 2012 Feb 01; 18(3):619-24. PubMed ID: 22298894
    [Abstract] [Full Text] [Related]

  • 4. Personalized oncology: recent advances and future challenges.
    Kalia M.
    Metabolism; 2013 Jan 01; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [Abstract] [Full Text] [Related]

  • 5. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD.
    Z Evid Fortbild Qual Gesundhwes; 2012 Jan 01; 106(1):11-22. PubMed ID: 22325103
    [Abstract] [Full Text] [Related]

  • 6. Progress towards personalized medicine.
    Bates S.
    Drug Discov Today; 2010 Feb 01; 15(3-4):115-20. PubMed ID: 19914397
    [Abstract] [Full Text] [Related]

  • 7. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH.
    Expert Rev Mol Diagn; 2010 Jan 01; 10(1):33-48. PubMed ID: 20014921
    [Abstract] [Full Text] [Related]

  • 8. Personalized-medicine trials on the rise.
    Benowitz S.
    J Natl Cancer Inst; 2012 Oct 03; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract] [Full Text] [Related]

  • 9. NCI-MATCH launch highlights new trial design in precision-medicine era.
    McNeil C.
    J Natl Cancer Inst; 2015 Jul 03; 107(7):. PubMed ID: 26142446
    [No Abstract] [Full Text] [Related]

  • 10. Personalized medicine for metastatic breast cancer.
    Chen TW, Bedard PL.
    Curr Opin Oncol; 2013 Nov 03; 25(6):615-24. PubMed ID: 24097103
    [Abstract] [Full Text] [Related]

  • 11. Personalizing oncology: perspectives and prospects.
    Mendelsohn J.
    J Clin Oncol; 2013 May 20; 31(15):1904-11. PubMed ID: 23589547
    [Abstract] [Full Text] [Related]

  • 12. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
    Scolyer RA, Thompson JF.
    J Surg Oncol; 2013 Jun 20; 107(7):681-2. PubMed ID: 23280671
    [No Abstract] [Full Text] [Related]

  • 13. Oncology trials gear up for high-throughput sequencing.
    Mullard A.
    Nat Rev Drug Discov; 2012 Apr 30; 11(5):339-40. PubMed ID: 22543457
    [No Abstract] [Full Text] [Related]

  • 14. Clinical cancer genomics: how soon is now?
    Taylor BS, Ladanyi M.
    J Pathol; 2011 Jan 30; 223(2):318-26. PubMed ID: 21125684
    [Abstract] [Full Text] [Related]

  • 15. The journey toward personalized cancer therapy.
    Tulbah A, Chaudhri N, Al Dayel F, Akhtar M.
    Adv Anat Pathol; 2014 Jan 30; 21(1):36-43. PubMed ID: 24316909
    [Abstract] [Full Text] [Related]

  • 16. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C, Caldas C.
    Ann N Y Acad Sci; 2010 Oct 30; 1210():34-44. PubMed ID: 20973797
    [Abstract] [Full Text] [Related]

  • 17. [Chemotherapy for malignant tumors: problems and prospects].
    Orlova RV, Vaizyan RI, Ivanova AK, Tikhonova EK, Zorina EY.
    Vopr Onkol; 2015 Oct 30; 61(2):244-51. PubMed ID: 26087606
    [Abstract] [Full Text] [Related]

  • 18. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P.
    Cancer Chemother Pharmacol; 2003 Jul 30; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [Abstract] [Full Text] [Related]

  • 19. [Personalized therapeutic targeting by exome analysis].
    Lamy A, Angot E, Sabourin JC.
    Ann Pathol; 2012 Nov 30; 32(5 Suppl):S44-5. PubMed ID: 23127937
    [No Abstract] [Full Text] [Related]

  • 20. [Intraclonal heterogeneity in tumors and its impact on precision medicine].
    Roux J, Gouzé JL, Hofman P.
    Med Sci (Paris); 2015 Jan 30; 31(1):28-31. PubMed ID: 25658727
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.